Latest Retinitis pigmentosa Stories
NEW YORK, Aug.
Researchers at the University of Massachusetts Medical School (UMMS) believe they may have found a new treatment for retinitis pigmentosa (RP), a severe neurodegenerative disease of the retina that ultimately results in blindness.
TOKYO, July 15 /PRNewswire/ -- R-Tech Ueno, Ltd. announced on July 15 the completion of the Phase II clinical study on the ophthalmic solution UF-021 (product name Ocuseva (TM)) under development as a therapeutic drug for retinitis pigmentosa (Note 1).
Scientists from The Vision Centre have reported remarkable progress in developing ways to restore sight to people suffering from age-related vision loss.
It's safe to say that cilia, the hairlike appendages jutting out from the smooth surfaces of most mammalian cells, have long been misunderstood â€“ underestimated, even.
Retinitis pigmentosa affects over one million people worldwide and is manifested by a progressive loss of sight, eventually leading to blindness.
Usher syndrome (USH), an inherited condition involving both hearing and vision loss, is not a simply recessively inherited disease.
Researchers working toward cure for pigmentosa; other retinal diseases.
TOKYO, June 3 /PRNewswire/ -- We are pleased to announce that the Phase II clinical study of UF-021, product name Ocuseva (TM), which we are developing as a therapeutic drug for retinitis pigmentosa (note 1), has been completed. Retinitis pigmentosa is an intractable disease where therapeutic drugs or therapeutic methods have not been established yet.
Complex tissue structure â€“ a first â€“ offers hope to millions with degenerative eye disorders.
- A trick or prank.